Company Filing History:
5 out of 320 
1 out of 91 
1 out of 47 Years Active: 2008-2019
Title: The Innovations of Francois-Xavier Le Gros
Introduction
Francois-Xavier Le Gros is a notable inventor based in Saint Genis Laval, France. He has made significant contributions to the field of microbiology and vaccine development. With a total of 7 patents to his name, his work has had a considerable impact on the scientific community.
Latest Patents
Le Gros's latest patents include a groundbreaking invention related to attenuated gram-negative bacteria. This invention discloses and claims a mutant of a gram-negative bacterium, which has at least one mutation in a nucleotide sequence coding for a polypeptide with a high degree of identity to specific amino acid sequences. The mutation results in attenuated virulence, making it a potential candidate for immunogenic compositions and vaccines. Another significant patent involves a method for producing the flu virus, showcasing his expertise in virology and infectious diseases.
Career Highlights
Throughout his career, Le Gros has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notably, he has been associated with Merial Limited and Sanofi Pasteur, where he contributed to various innovative projects aimed at improving public health through advanced vaccine technologies.
Collaborations
Le Gros has collaborated with esteemed colleagues, including Helen Rachel Crooke and Jacqueline Elizabeth Shea. These partnerships have fostered a collaborative environment that has led to the advancement of research and development in their respective fields.
Conclusion
Francois-Xavier Le Gros is a distinguished inventor whose work in microbiology and vaccine development continues to influence the scientific landscape. His innovative patents and collaborations highlight his commitment to advancing healthcare solutions.